Payment is a benefit and why it matters for pediatric trials
Alan Wertheimer has argued persuasively that research ethics committees should be willing to count payment as a benefit when evaluating studies' risk–benefit ratios. In this paper, I begin by first recapitulating his argument and adding my own, complementary one. I then do two further things. F...
| 主要作者: | |
|---|---|
| 格式: | 电子 文件 |
| 语言: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | 载入...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| 出版: |
Wiley-Blackwell
2022
|
| In: |
Bioethics
Year: 2022, 卷: 36, 发布: 7, Pages: 757-764 |
| IxTheo Classification: | NCH Medical ethics NCJ Ethics of science |
| Further subjects: | B
benefit analyses / risk
B research ethics B children and families |
| 在线阅读: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |